Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - April 2002

  1. Shortage of varicella and measles, mumps and rubella vaccines and interim recommendations from the Advisory Committee on Immunization Practices  MMWR CDC Surveill Summ.  3-8-2002, 51 (9): 190-191.

  2. From the Centers for Disease Control. Status of US Department of Defense preliminary evaluation of the association of anthrax vaccination and congenital anomalies  JAMA.  3-6-2002, 287 (9): 1107.

  3. Time to look beyond MMR in autism research  Lancet.  2-23-2002, 359 (9307): 637.

  4. From the Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage--Advisory Committee on Immunization Practices  JAMA.  2002, %20;287 (7): 833-834.

  5. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). NACI update to statement on varicella vaccine  Can.Commun.Dis.Rep.  2-15-2002, 28:1-7. (): 1-7.

  6. Bibliography. Current world literature. Infectious diseases and immunization  Curr.Opin.Pediatr.  2002, 14 (1): 138-147.

  7. Small improvements seen in patient, staff vaccinations  Nephrol.News Issues.  2002, 16 (3): 18-25.

  8. Barton, L. L.  Immunology series: vaccines  N.Engl.J.Med.  3-14-2002, 346 (11): 864-866.

  9. Bond, L., Davie, G., Carlin, J. B., Lester, R., and Nolan, T.  Increases in vaccination coverage for children in child care, 1997 to 2000: an evaluation of the impact of government incentives and initiatives  Aust.N.Z.J.Public Health.  2002, 26 (1): 58-64.

  10. Bradbury, J.  USA to increase smallpox vaccine stockpile  Lancet Infect.Dis.  2001, 1 (5): 290.

  11. Bradshaw, J. and Wright, P. F.  Cold-adapted influenza vaccines  Curr.Opin.Pediatr.  2002, 14 (1): 95-98.

  12. Burton, A. Spain says good-bye to measles  Lancet Infect.Dis.  2001, 1 (3): 142.

  13. Chan, L., Maclehose, R. F., and Houck, P. M.  Impact of physician reminders on the use of influenza vaccinations: A randomized trial  Arch.Phys.Med.Rehabil.  2002, 83 (3): 371-375.

  14. Cohen, R., Aujard, Y., Bingen, E., Boucherat, M., Bourrillon, A., Foucaud, P., Francois, M., Garnier, J. M., Guillot, M., Ovetchkine, P., Ployet, M. J., Quinet, B., and Gaudelus, J.  [Therapeutic approaches in children immunized with vaccine Prevenar]  Arch.Pediatr.  2002, 9 (1): 4-6.

  15. Diodati, C.  Mandatory vaccination of health care workers  CMAJ.  2-5-2002, 166 (3): 301-302.

  16. Donlin, J.  The influenza vaccine  NCSL.Legisbrief.  2002, 10 (17): 1-2.

  17. Garcia-Doval, I., Roson, E., Feal, C., De la, Torre C., Rodriguez, T., and Cruces, M. J.  Generalized bullous fixed drug eruption after influenza vaccination, simulating bullous pemphigoid  Acta Derm.Venereol.  2001, 81 (6): 450-451.

  18. Georgitis, J. W. and Fasano, M. B.  Allergenic components of vaccines and avoidance of vaccination-related adverse events  Curr.Allergy Rep.  2001, 1 (1): 11-17.

  19. Gold, M. S.  Hypotonic-hyporesponsive episodes following pertussis vaccination: a cause for concern?  Drug Saf.  2002, 25 (2): 85-90.

  20. Grabenstein, J. D., Guess, H. A., Hartzema, A. G., Koch, G. G., and Konrad, T. R.  Attitudinal factors among adult prescription recipients associated with choice of where to be vaccinated  J.Clin.Epidemiol.  2002, 55 (3): 279-284.

  21. Hackley, B. K.  Controversies in immunization practices: vaccine safety and implications for midwifery practice  J.Midwifery Womens Health.  2002, 47 (1): 16-27.

  22. Hahne, S. J., Gray, S. J., Jean, Francois, Aguilera, Crowcroft, N. S., Nichols, T., Kaczmarski, E. B., and Ramsay, M. E.  W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001  Lancet.  2-16-2002, 359 (9306): 582-583.

  23. Howe, M.  Pneumoccocal vaccination programme begins in Australia  Lancet Infect.Dis.  2001, 1 (2): 69.

  24. Hull, H. F.  The future of polio eradication  Lancet Infect.Dis.  2001, 1 (5): 299-303.

  25. Jentoft, H. F., Omenaas, E., Eide, G. E., and Gulsvik, A.  Absence of relationship between tuberculin reactivity and asthmatic symptoms, level of FEV1 and bronchial hyperresponsiveness in BCG vaccinated young adults  Allergy.  2002, 57 (4): 336-340.

  26. Josefson, D.  US encourages flu jabs for infants aged under 2  BMJ.  3-2-2002, 324 (7336): 502.

  27. Klugman, K. P.  Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance  Lancet Infect.Dis.  2001, 1 (2): 85-91.

  28. Kudesia, G., Partridge, S., Farrington, C. P., and Soltanpoor, N.  Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy  J.Clin.Pathol.  2002, 55 (2): 154-155.

  29. Lacson, A. G., D'Cruz, C. A., Gilbert-Barness, E., Sharer, L., Jacinto, S., and Cuenca, R.  Aluminum Phagocytosis in Quadriceps Muscle following Vaccination in Children: Relationship to Macrophagic Myofasciitis  Pediatr.Dev.Pathol.  2002, 5 (2): 151-158.

  30. Levy-Bruhl, D.  [What place for BCG vaccination in France?]  Arch.Pediatr.  2002, 9 (1): 1-3.

  31. Levy-Bruhl, D. and Guerin, N.  The use of smallpox virus as a biological weapon: the vaccination situation in France  Euro.Surveill.  2001, 6 (11): 171-178.

  32. Lista, F., Faggioni, G., Peragallo, M. S., Tontoli, F., Stella, A., Salvatori, P., Pusino, M., Germani, M. A., Contreas, V., and D'Amelio, R.  Molecular analysis of early postvaccine mumps-like disease in Italian military recruits  JAMA.  3-6-2002, 287 (9): 1114-1115.

  33. Meyers, D. G. and Jurisich, P. D.  Could vaccinations prevent myocardial infarction?  Am.J.Cardiol.  3-15-2002, 89 (6): 723-725.

  34. Moreton, J.  MMR vaccination: the case for evidence-based practice  Br.J.Community Nurs.  2001, 6 (4): 199-200.

  35. Obaro, S. and Adegbola, R.  The pneumococcus: carriage, disease and conjugate vaccines  J.Med.Microbiol.  2002, 51 (2): 98-104.

  36. Orellana, C.  Mexican vaccine against typhoid fever in phase I trial  Lancet Infect.Dis.  2001, 1 (5): 292.

  37. Osterholm, M. T.  How to vaccinate 30,000 people in three days: realities of outbreak management  Public Health Rep.  2001, 116 Suppl 2:74-8. (): 74-78.

  38. Paterson, R.  Human trials start for new tuberculosis vaccine  Lancet Infect.Dis.  2001, 1 (5): 291.

  39. Persaude, D., Teape-Humphrey, L., Adelstein, R., Domb, S., and Jaakkimainen, L.  Peril of the pox. Are primary care providers aware of varicella vaccination guidelines?  Can.Fam.Physician.  2002, 48:316-23. (): 316-323.

  40. Peterson, D. C., Bahta, L., and Ehresmann, K.  Vaccinating adults for vaccine-preventable diseases  Minn.Med.  2002, 85 (2): 37-39.

  41. Pollard, A. J. and Scheifele, D.  Meningococcal disease and vaccination in North America  J.Paediatr.Child Health.  2001, 37 (5): S20-S27.

  42. Rehme, P. A., Williams, R., and Grabenstein, J.  Ambulatory medical visits among anthrax-vaccinated and unvaccinated personnel after return from southwest Asia  Mil.Med.  2002, 167 (3): 205-210.

  43. Reinert, P.  The role of pneumococcal and haemophilus type B vaccination in the prevention of acute otitis media  Clin.Microbiol.Infect.  1997, 3 Suppl 3:S59-S61. (): S59-S61.

  44. Rokicka-Milewska, R., Machala, M., Klukowska, A., Laguna, P., and Sikorska-Fic, B.  Efficacy of subunit trivalent influenza vaccine in previously vaccinated children suffering from hemophilia  Clin.Microbiol.Infect.  1998, 4 (10): 589-593.

  45. Rothberg, M., Bennish, M. L., Kao, J. S., and Wong, J. B.  Do the benefits of varicella vaccination outweigh the long-term risks? A decision-analytic model for policymakers and pediatricians  Clin.Infect.Dis.  4-1-2002, 34 (7): 885-894.

  46. Silvers, L. E., Varricchio, F. E., Ellenberg, S. S., Krueger, C. L., Wise, R. P., and Salive, M. E.  Pediatric deaths reported after vaccination: the utility of information obtained from parents  Am.J.Prev.Med.  2002, 22 (3): 170-176.

  47. Skull, S. A. and Butler, J. R.  Meningococcal vaccination for adolescents? An economic evaluation in Victoria  J.Paediatr.Child Health.  2001, 37 (5): S28-S33.

  48. Sparkes, A. H.  Towards a more rational and scientific approach to vaccination  J.Feline.Med.Surg.  2001, 3 (2): 45-46.

  49. St, S., Jacobson, R. M., Vierkant, R. A., Jacobsen, S. J., Green, E. M., and Poland, G. A.  Association of parental vaccination reports with measles, mumps, and rubella protective antibody levels: comparison of Somali immigrant, Hispanic migrant, and US children in Rochester, Minn  Mayo Clin.Proc.  2002, 77 (3): 241-245.

  50. Stevenson, J., Massoudi, M., Stokley, S., and Bulim, I.  Clinical assessment software application (CASA) and immunization coverage rates  Am.J.Public Health.  2002, 92 (3): 333-334.

  51. Stevenson, M., Beard, S., Finn, A., and Brennan, A.  Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule  Vaccine.  3-15-2002, 20 (13): 1778-1786.

  52. Tschantz, K. and Foley, L. A.  Lifesaving opportunities missed: the challenge of vaccinating older Americans for pneumococcal diseases and influenza  Issue.Brief.(Public Policy Inst.(Am.Assoc.Retired.Pers.)).  2000, IB45): 1-9.

  53. van den, Hof S., Wallinga, J., Widdowson, M. A., and Conyn-van Spaendonck, M. A. E.  Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules  Epidemiol.Infect.  2001, 128 (1): 47-57.

  54. Wettendorff, M.  Therapeutic vaccination  Virus Res.  1-30-2002, 82 (1-2): 133-140.

  55. Wiesen, A. R. and Littell, C. T.  Relationship Between Prepregnancy Anthrax Vaccination and Pregnancy and Birth Outcomes Among US Army Women  JAMA.  3-27-2002, 287 (12): 1556-1560.

Back to Top